Notificação de acontecimentos adversos ou reclamações de qualidade
AZ Medical Global

Áreas Terapêuticas
Medicamentos
Recursos
Conectar

Login

Search Medical Information

Para pesquisar informação científica, deverá especificar pelo menos dois termos de pesquisa

Search Medical Information

American Heart Association (AHA 2024)

November 16 - 18, 2024

FARXIGA (dapagliflozin)
WAINUA (eplontersen)
LOKELMA (sodium zirconium cyclosilicate)
Heart Failure

pdf

Effect of Time Since Heart Failure Diagnosis or Hospitalisation on the Cost-effectiveness of Dapagliflozin in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction

html

Galectin-3 and Progression of Kidney Disease in Patients with Type 2 Diabetes Mellitus: Analyses From the DECLARE-TIMI 58 Trial

html

Defining “Advanced Heart Failure” across the Ejection Fraction Spectrum in DAPA-HF and DELIVER

html

Age, Adiposity-Related Anthropometrics, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Trials

html

Sex, Adiposity-Related Anthropometrics, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Trials

PDF

External Validation of EchoNet-LVH, a Deep Learning Model for Cardiac Amyloidosis for Association with Cardiomyopathy.

pdf

Hyperkalemia-Related Hospitalization Associated with Short-Term vs. Long-Term Outpatient SZC Therapy Among RAASi Users: The GALVANIZE Outcome study

HTML

Effects of Sodium Zirconium Cyclosilicate on Optimizing Mineralocorticoid Receptor Antagonist use in Patients with Heart Failure and Reduced Ejection Fraction and Hyperkalemia: Results from REALIZE-K Randomized Controlled Trial

pdf

Sodium zirconium cyclosilicate and MRA optimization in heart failure with reduced ejection fraction and hyperkalemia: main results from REALIZE-K randomized controlled trial

pdf

Myeloperoxidase Inhibition with Mitiperstat in HFpEF and HFmrEF: Primary Results of the ENDEAVOR Randomized Clinical Trial

html

Polygenic Risk in Heart Failure – Evaluating the Ability of a Polygenic Risk Score to Identify Risk of Future Heart Failure Events in 60,000 Patients from 6 TIMI Randomized Trials

HTML

Obesity and Risk of Kidney Outcomes in Heart Failure with Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials

html

Hispanic/Latino Patients with Heart Failure with Preserved Ejection Fraction: A Participant Level Pooled Analysis of 3 Contemporary Trials

Não encontra o que procura?

Contacte-nos

Encontre um Medical Healthcare Partner

Submeter uma questão

A informação incluída neste website é dirigida exclusivamente a profissionais de saúde.

©2024 AstraZeneca. Todos os direitos reservados. PT-19636

Aprovado a 12/2024.

Sobre o AZMedical

AstraZeneca Portugal

Inquérito de Satisfação

Política de Privacidade

Aviso Legal e Termos de Utilização

Notificação de acontecimentos adversos ou reclamações de qualidade

Política de Privacidade

Aviso Legal e Termos de Utilização